Oxidative stress in chronic obstructive pulmonary disease: A lung and systemic process

Canadian Respiratory Journal

Volumn 20, Issue 1, 2013, Pages 27-29

  Van Eeden, Stephan F ^a   Sin, Don D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; MALONALDEHYDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

AIR POLLUTANT; ANTIOXIDANT RESPONSIVE ELEMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DNA DAMAGE; EDITORIAL; ENVIRONMENTAL EXPOSURE; HUMAN; LIPID PEROXIDATION; LUNG ALVEOLUS MACROPHAGE; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG INFECTION; OXIDATIVE STRESS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC CIRCULATION; TISSUE REPAIR;

EID: 84876226215     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/509130     Document Type: Editorial

References (31)

1. Rahman I, MacNee W. Role of oxidants/antioxidants in smokinginduced lung diseases. Free Radic Biol Med 1996:21:669-81.
2. Anderson D, Macnee W. Targeted treatment in COPD: A multi-system approach for a multi-system disease. Int J Chron Obstruct Pulmon Dis 2009:4:321-35.
3. Rahman I, MacNee W. Lung glutathione and oxidative stress: Implications in cigarette smoke-induced airway disease. Am J Physiol 1999:277:L1067-088.
4. Yoshida T, Tuder RM. Pathobiology of cigarette smoke induced chronic obstructive pulmonary disease. Physiol Rev 2007;87:1047-82.
5. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006:28:219-42.
6. Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, Kurose H. G[alpha]i and G[alpha]o are target proteins of reactive oxygen species. Nature 2000:408 492-5.
7. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem 2004:11:1163-82.
8. Aoshiba K, Nagai A. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:596-601.
9. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006;174:886-93.
10. Churg A, Wright JL. Proteases and emphysema. Curr Opin Pulm Med 2005;11:153-9.
11. Cavarra E, Lucattelli M, Gambelli F, et al. Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress. Am J Physiol Lung Cell Mol Physiol 2001;281:L412-L417.
12. Snider GL. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Annu Rev Med 1989:40:411-29.
13. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985:64:111-26.
14. Kluchova Z, Petrasova D, Joppa P, Dorkova Z, Tkacova R. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 2007;56:51-6.
15. Montano M, Cisneros J, Ramirez-Venegas A, et al. Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking. Inhal Toxicol 2010;22:868-74.
16. Pinamonti S, Leis M, Barbieri A, et al. Detection of xanthine oxidase activity products by EPR and HPLC in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free Radic Biol Med 1998:25:771-9.
17. Janssen-Heininger YM, Persinger RL, Korn SH, et al. Reactive nitrogen species and cell signaling: Implications for death or survival of lung epithelium. Am J Respir Crit Care Med 2002:166:9S-16S.
18. Lanzetti M, da Costa CA, Nesi RT, et al. Oxidative stress and nitrosative stress are involved in different stages of proteolytic pulmonary emphysema. Free Radic Biol Med 2012;53:1993-2001.
19. Boutten A, Goven D, Boczkowski J, Bonay M. Oxidative stress targets in pulmonary emphysema: Focus on the NRF2 pathway. Expert Opin Ther Targets 2010:14:329-46.
20. Kensler TW, et al. Cell survival responses to environmental stresses via the Keap1-NRF2-ARE pathway. Annu Rev Pharmacol Toxicol 2007:47:89-116.
21. Malhotra D, Thimmulappa R, Navas-Acien A, et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 2008;178:592-604.
22. Zeng M, Li Y, Jiang Y, Lu G, Huang X, Guan K. Local and systemic oxidative stress and glucocorticoid receptor in chronic obstructive pulmonary disease patients. Can Resp J 2012:35-41.
23. van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: A chronic systemic inflammatory disease. Respiration 2008:75:224-38.
24. Van Eeden SF, Leipsic J, Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Resp Crit Care Med 2012:186:11-6.
25. Tamagawa E, Suda K, Yuan W, et al. Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immun 2009:15:251-8.
26. Kido T, Tamagawa E, Bai N, et al. Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol Biol 2011;44:197-204.
27. Suda K, Tsuruta M, Eom J, et al. Acute lung injury induces cardiovascular dysfunction: Effects of IL-6 and budesonide/formoterol. Am J Respir Cell Mol Biol 2011;45:510-6.
28. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12.
29. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-8.
30. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with communityacquired pneumonia: Incidence, timing, risk factors, and association with short term mortality. Circulation 2012;125:773-81.
31. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2008;2:351.